{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-26-000027","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2026-08-11T20:07:42+00:00","discovered_at":"2026-08-11T20:09:01.355748+00:00","generated_at":"2026-08-11T20:09:32.523447+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroPace Q2 revenue $22.8M (+17% YoY); raises FY26 revenue guidance","bullets":["Q2 2026 RNS revenue $22.5M, up 21.3% YoY; total revenue $22.8M vs $19.5M in Q2 2025.","GAAP net loss narrowed to ($6.2)M from ($10.0)M YoY; Adjusted EBITDA loss improved to ($2.8)M from ($4.9)M.","FY26 revenue guidance raised to $99.5M-$101.5M (from $99M-$101M); Adjusted EBITDA guided to ($7.5)M-($8.5)M.","Launched ECoG Assistant AI decision-support tool; NAUTILUS 18-month data showed 77% median GTC seizure reduction.","Cash $51.9M at June 30, 2026; DIXI product operations presented as discontinued; long-term borrowings $59.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-26-000027","json":"https://secwatch.observer/filing/0001528287-26-000027.json","markdown":"https://secwatch.observer/filing/0001528287-26-000027.md","text":"https://secwatch.observer/filing/0001528287-26-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/0001528287-26-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828726000027/npce-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T20:09:32.523447+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}